Clinuvel Pharmaceuticals | CUV - Sales Revenues

Stock Price
9.05
Daily Change
-0.27 -2.90%
Monthly
-10.22%
Yearly
-16.67%
Q2 Forecast
8.82

Clinuvel Pharmaceuticals reported AUD36.93M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Avita Medical AUD 17.61M 805K Dec/2025
Medical Developments International AUD 21.57M 12.04M Dec/2025
Mesoblast USD 51.34M 38.14M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Pacific Edge NZD 5.94M 4.95M Dec/2025
Paradigm Biopharmaceuticals AUD 284.06K 292.06K Dec/2025
PYC Therapeutics AUD 11.04M 2.44M Dec/2025
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025